首页> 外文期刊>Renal replacement therapy. >Peritonitis in peritoneal dialysis patients in Japan: a 2013 retrospective questionnaire survey of Japanese Society for Peritoneal Dialysis member institutions
【24h】

Peritonitis in peritoneal dialysis patients in Japan: a 2013 retrospective questionnaire survey of Japanese Society for Peritoneal Dialysis member institutions

机译:日本腹膜透析患者的腹​​膜炎:日本腹膜透析学会会员机构2013年回顾性问卷调查

获取原文
           

摘要

Background Peritonitis is the main cause of withdrawal from peritoneal dialysis (PD) therapy in Japan. The precise extent of PD-associated peritonitis in Japan has not been investigated since 2005; we aimed to clarify the recent incidence and prognosis of PD peritonitis. Methods The 248 institutional members of the Japanese Society for Peritoneal Dialysis were surveyed by questionnaire regarding peritonitis episodes during January 1 to December 31, 2013. Results Replies from 114 members were received regarding 3042 PD patients, including 516 peritonitis patients, covering a total observation period of 31,686 patient months. The incidence of peritonitis in this study was 0.195 episodes per year. Detailed data on 544 peritonitis episodes in 466 patients was obtained. The causes, in ranked order, were unknown reason, contamination at peritoneal fluid exchange, and extension of intra-abdominal cavity infection. Effluent culture methods included using a blood culture bottle (50.9?%), large-volume culture (culturing sediment after centrifuging effluent) (31.7?%), and direct culture of effluent using a culture dish (12.7?%). The rank order of microbes identified in peritoneal effluent cultures was culture-negative, Streptococcus sp. and Staphylococcus aureus . Empiric therapy with two kinds of antibiotics was administered to 406 cases (75.2?%), most commonly cefazolin + ceftazidime. Antibiotic administration methods included intraperitoneal (51.4?%), intravenous (46.4?%), and oral (2.2?%). After a peritonitis episode, 461 patients (84.7?%) continued PD therapy, 80 (14.7?%) withdrew from PD treatment, and 6 (1.1?%) died. Prognosis among patients grouped by antibiotic administration method was statistically significantly different; in the oral administration group, the rates of mortality and catheter replacement were higher. Logistic regression analysis showed that catheter exit-site infection and frequency of past peritonitis episodes were independent factors associated with PD treatment withdrawal. Conclusions Although the overall incidence of PD peritonitis in Japan was relatively low, several areas for future improvement were identified: unknown reason and culture-negative were the most frequently cited causes of peritonitis; 1.1?% of patients died, and 13.6?% discontinued PD therapy. Improvements in effluent culture techniques, antibiotic administration methods, etiology determination, and patient education could help. A more effective protocol must be established to further improve the treatment of PD peritonitis in Japan.
机译:背景技术腹膜炎是日本退出腹膜透析(PD)治疗的主要原因。自2005年以来,日本尚未对PD相关性腹膜炎的确切范围进行调查。我们旨在阐明PD腹膜炎的近期发病率和预后。方法采用问卷调查法,对2013年1月1日至12月31日日本腹膜透析学会的248名机构成员进行了腹膜炎发作调查。结果共收到114例患者的3042例PD患者的反馈意见,其中516例为腹膜炎患者,整个观察期31,686病人月。这项研究中腹膜炎的发生率为每年0.195次。获得了466例患者中544例腹膜炎发作的详细数据。病因排名不明,原因不明,腹膜液交换污染和腹腔感染扩大。废水培养方法包括使用血培养瓶(50.9%),大容量培养(离心废水后培养沉淀物)(31.7%)和使用培养皿直接培养废水(12.7%)。在腹膜流出物培养物中鉴定出的微生物的等级顺序是培养阴性的链球菌。和金黄色葡萄球菌。 406例(占75.2%)采用了两种抗生素的经验疗法,最常见的是头孢唑林+头孢他啶。抗生素给药方法包括腹膜内(51.4%),静脉内(46.4%)和口服(2.2%)。腹膜炎发作后,有461例患者(84.7%)继续接受PD治疗,退出PD治疗的患者80例(14.7%),死亡6例(1.1%)。抗生素给药方法分组的患者的预后有统计学差异;口服给药组的死亡率和导管更换率更高。 Logistic回归分析表明,导管出口部位感染和既往腹膜炎发作的频率是与PD治疗停药相关的独立因素。结论尽管日本PD腹膜炎的总发病率相对较低,但仍确定了未来有待改善的领域:未知原因和培养阴性是腹膜炎最常提及的原因; 1.1%的患者死亡,13.6%的患者停止PD治疗。废水培养技术,抗生素施用方法,病因学确定和患者教育方面的改进可能会有所帮助。在日本,必须建立更有效的方案以进一步改善PD腹膜炎的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号